Literature DB >> 11753089

Renal blood flow autoregulation in blood pressure control.

Pontus B Persson1.   

Abstract

Although the kidney strives to maintain its perfusion within tight boundaries, considerable blood flow fluctuations do occur. The reasons for this are the rather slow acting compensatory mechanisms of renal blood flow autoregulation, the effects of renal nerves, hormonal influences, etc. It seems that variations in renal perfusion can exert a major influence on renal excretory functions, on renin release and on blood pressure. The clinical importance of renal blood flow variability is not fully understood. In many situations, the absence of normal cardiovascular oscillations seems to be a risk factor. Large fluctuations in perfusion pressure to the kidney, however, in the long run, may induce target organ damage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11753089     DOI: 10.1097/00041552-200201000-00010

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  11 in total

1.  Noradrenaline and the kidney: foe, friend, or both?

Authors:  Martin Matejovic; Karl Träger; Daniel De Backer
Journal:  Intensive Care Med       Date:  2005-08-09       Impact factor: 17.440

2.  ATP, P2 receptors and the renal microcirculation.

Authors:  Edward W Inscho
Journal:  Purinergic Signal       Date:  2009-03-18       Impact factor: 3.765

3.  Renal blood flow and dynamic autoregulation in conscious mice.

Authors:  Radu Iliescu; Radu Cazan; Gerald R McLemore; Marcia Venegas-Pont; Michael J Ryan
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-25

4.  Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib.

Authors:  Tasuku Nagasawa; Md Abdul Hye Khan; John D Imig
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-05       Impact factor: 2.557

5.  Enhanced hemodynamic responses to angiotensin II in diabetes are associated with increased expression and activity of AT1 receptors in the afferent arteriole.

Authors:  Jie Zhang; Helena Y Qu; Jiangping Song; Jin Wei; Shan Jiang; Lei Wang; Liqing Wang; Jacentha Buggs; Ruisheng Liu
Journal:  Physiol Genomics       Date:  2017-08-25       Impact factor: 3.107

Review 6.  Purinoceptor: a novel target for hypertension.

Authors:  Xuan Li; Li-Juan Zhu; Jing Lv; Xin Cao
Journal:  Purinergic Signal       Date:  2022-02-18       Impact factor: 3.765

Review 7.  P2 receptors in renal autoregulation.

Authors:  Zhengrong Guan; Robert C Fellner; Justin Van Beusecum; Edward W Inscho
Journal:  Curr Vasc Pharmacol       Date:  2014       Impact factor: 2.719

8.  Lewis K. Dahl Memorial Lecture. Mysteries of renal autoregulation.

Authors:  Edward W Inscho
Journal:  Hypertension       Date:  2008-12-08       Impact factor: 10.190

9.  Disease-modifying medications in heart failure: more than ACE inhibitors and beta blockers.

Authors:  Chia Ter Chao
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

10.  Contrast-enhanced ultrasonography to evaluate changes in renal cortical microcirculation induced by noradrenaline: a pilot study.

Authors:  Antoine G Schneider; Mark D Goodwin; Anthony Schelleman; Michael Bailey; Lynne Johnson; Rinaldo Bellomo
Journal:  Crit Care       Date:  2014-12-02       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.